Harnessing skull immunity for brain drug delivery

Area of Science:

• Neuroscience
• Immunology
• Biomedical Engineering

Background:

• The blood-brain barrier (BBB) severely restricts therapeutic access to the brain, posing a significant challenge for treating neurological disorders like stroke.
• Effective drug delivery to injured brain regions is crucial for improving patient outcomes after stroke.

Purpose of the Study:

• To investigate a novel strategy for bypassing the blood-brain barrier to deliver therapeutics to the brain.
• To utilize immune cells from skull bone marrow for targeted drug delivery to stroke-affected brain areas.

Main Methods:

• Drug-loaded nanoparticles were engineered for delivery.
• Skull bone marrow immune cells were harnessed to transport these nanoparticles.
• The delivery system's efficacy was evaluated in preclinical models of stroke.

Main Results:

• The engineered immune cells successfully transported drug-loaded nanoparticles across the blood-brain barrier.
• Targeted delivery to injured brain regions was achieved.
• Significant improvements in neurological outcomes were observed in stroke models.

Conclusions:

• Harnessing skull bone marrow immune cells presents a feasible and translational strategy for targeted central nervous system (CNS) therapy.
• This approach offers a promising method to overcome the limitations of the blood-brain barrier for brain drug delivery.